Synthetic genomic variant-based secure transaction devices, systems and methods

US10050959B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10050959-B2
Application numberUS-201514844974-A
CountryUS
Kind codeB2
Filing dateSep 3, 2015
Priority dateSep 3, 2014
Publication dateAug 14, 2018
Grant dateAug 14, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various devices, systems, structures and methods are disclosed related to securely authorizing a transaction by synchronizing digital genomic data with associated synthetic genomic variants. An embodiment of the present invention utilizes digital genomic data associated with an entity, such as a person, who may utilize a genome-based security device to complete a transaction. In one embodiment, a person may use a genome-based security device to communicate with an external device over a wireless or other communication interface, synchronize digital genomic data and an associated synthetic variant received from the external device with digital genomic data and associated synthetic variant stored on the genome-based security device.

First claim

Opening claim text (preview).

What is claimed is: 1. A genome-based security device comprising: a memory storing digital genomic data associated with at least one entity, wherein the digital genomic data comprises at least one synthetic variant and actual genomic data unique to the at least one entity wherein the at least one synthetic variant is different from the actual genomic data; wherein the at least one synthetic variant includes altered non-neighboring base pairs spread across the actual genomic data; a hardware processing unit configurable to execute instructions which upon execution: synchronizes the digital genomic data comprising the at least one synthetic variant and actual genomic data with external digital genomic data comprising at least one external synthetic variant and external actual genomic data unique to the at least one entity and received from an external device; by generating the at least one synthetic variant through applying one or more predetermined time-based transformation functions implemented by inputting one or more predetermined time-based value keys combined with one or more predetermined data selections to create the at least one synthetic variant; and authorizes a transaction upon synchronization of the at least one synthetic variant with respect to the at least one external synthetic variant; and a communication interface coupled with the processing unit configured to communicatively couple with the external device and operable to receive the at least one external synthetic variant from the external device. 2. The genome-based security device of claim 1 , wherein the digital genomic data comprises at least a portion of an exome associated with the at least one entity. 3. The genome-based security device of claim 2 , wherein the at least one synthetic variant is disposed within the at least a portion of the exome associated with the at least one entity. 4. The genome-based security device of claim 3 , wherein the at least one entity comprises a human being. 5. The genome-based security device of claim 1 , wherein the at least one synthetic variant comprises a single nucleotide polymorphism (SNP). 6. The genome-based security device of claim 5 , wherein the at least one synthetic variant comprises a set of SNPs. 7. The genome-based security device of claim 1 , wherein the at least one synthetic variant comprises at least 100 base pairs. 8. The genome-based security device of claim 7 , wherein the at least one synthetic variant comprises at least 10,000 base pairs. 9. The genome-based security device of claim 8 , wherein the at least one synthetic variant comprises at least 1,000,000 base pairs. 10. The genome-based security device of claim 1 , wherein the communication interface comprises a contact pad. 11. The genome-based security device of claim 1 , wherein the communication interface comprises a wireless interface. 12. The genome-based security device of claim 11 , wherein the wireless interface comprises a 60 GHz chip set. 13. The genome-based security device of claim 12 , wherein the wireless interface has a communication range of less than 10 cm. 14. The genome-based security device of claim 1 , wherein the memory comprises a secured portion that stores the at least one synthetic variant. 15. A computer program product comprising instructions stored in a non-transitory machine-readable medium, the instructions when executed by a device cause the device to perform: accessing on a memory of the device, a first set of digital genomic data associated with at least one entity, wherein the first set of digital genomic data comprises a first set of actual genomic data unique to the at least one entity and a first synthetic variant wherein the first synthetic variant is different from the first set of actual genomic data; wherein the first synthetic variant includes altered non-neighboring base pairs spread across the first set of actual genomic data unique to the at least one entity; receiving a second set of digital genomic data associated with the at least one entity from an external device, wherein the second set of digital genomic data comprises a second set of actual genomic data unique to the at least one entity and a second synthetic variant wherein the second synthetic variant is different from the second set of actual genomic data; and synchronizing the first set of digital genomic data with the second set of digital genomic data, by generating the first synthetic variant through applying one or more predetermined time-based transformation functions implemented by inputting one or more predetermined time-based value keys combined with one or more predetermined data selections to create the first synthetic variant; wherein a transaction for the at least one entity is authorized when the first synthetic variant matches the second synthetic variant. 16. A method of authorizing a transaction using genomic data stored on a device, comprising: accessing on a memory of the device, a first set of digital genomic data associated with at least one entity, wherein the first set of digital genomic data comprises a first set of actual genomic data unique to the at least one entity and a first synthetic variant wherein the first synthetic variant is different from the first set of actual genomic data; wherein the first synthetic variant includes altered non-neighboring base pairs spread across the first set of actual genomic data unique to the at least one entity; receiving a second set of digital genomic data associated with the at least one entity from an external device, wherein the second set of digital genomic data comprises a second set of actual genomic data unique to the at least one entity and a second synthetic variant wherein the second synthetic variant is different from the second set of actual genomic data; and synchronizing the first set of digital genomic data with the second set of digital genomic data, by generating the first synthetic variant through applying one or more predetermined time-based transformation functions implemented by inputting one or more predetermined time-based value keys combined with one or more predetermined data selections to create the first synthetic variant; wherein a transaction for the at least one entity is authorized when the first synthetic variant matches the second synthetic variant. 17. The method of claim 16 , wherein the transaction comprises a healthcare transaction. 18. The method of claim 16 , wherein the transaction comprises a commercial transaction. 19. The method of claim 16 , wherein the transaction comprises a financial transaction.

Assignees

Inventors

Classifications

  • using an additional device, e.g. smartcard, SIM or a different communication terminal (cryptographic mechanisms or cryptographic arrangements for entity authentication involving additional secure or trusted devices H04L9/3234) · CPC title

  • applying security measure for e-commerce · CPC title

  • using biometrical features, e.g. fingerprint, retina-scan (cryptographic mechanisms or cryptographic arrangements for entity authentication using biological data H04L9/3231) · CPC title

  • using biometric data, e.g. fingerprints, iris scans or voiceprints · CPC title

  • communicating wirelessly · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10050959B2 cover?
Various devices, systems, structures and methods are disclosed related to securely authorizing a transaction by synchronizing digital genomic data with associated synthetic genomic variants. An embodiment of the present invention utilizes digital genomic data associated with an entity, such as a person, who may utilize a genome-based security device to complete a transaction. In one embodiment,…
Who is the assignee on this patent?
Nanthealth Inc, Nant Holdings Ip Llc, Nantomics Llc
What technology area does this patent fall under?
Primary CPC classification H04L63/0861. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).